Koneksa grabs $45m Series C

Koneksa, a digital biomarker platform, has secured $45 million in Series C financing.

Koneksa, a digital biomarker platform, has secured $45 million in Series C financing. AyurMaya, an affiliated fund of Matrix Capital Management, led the round with participation from Takeda Ventures and Velosity Capital.

Source: Press Release